![NOVEL PHARMACEUTICAL USE OF THIOPHENE [3,2-D] PYRIMIDINE-4-KETONE COMPOUND](/docs/US/2021-01-21/US20210015824A1/abs.jpg.600x600.jpg)
- 专利标题： NOVEL PHARMACEUTICAL USE OF THIOPHENE [3,2-D] PYRIMIDINE-4-KETONE COMPOUND
-
申请号： US16978563申请日： 2019-03-08
-
公开(公告)号： US20210015824A1公开(公告)日： 2021-01-21
- 发明人: Hong LIU , Jia LI , Jiang WANG , Yi ZANG , Jian LI , Jingya LI , Dandan SUN , Hualiang JIANG , Kaixian CHEN
- 申请人： SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- 申请人地址： CN Shanghai
- 专利权人： SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- 当前专利权人： SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- 当前专利权人地址： CN Shanghai
- 优先权： CN201810194967.6 20180309
- 国际申请： PCT/CN2019/077560 WO 20190308
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; A61K31/519 ; A61P1/16
![NOVEL PHARMACEUTICAL USE OF THIOPHENE [3,2-D] PYRIMIDINE-4-KETONE COMPOUND](/abs-image/US/2021/01/21/US20210015824A1/abs.jpg.150x150.jpg)
摘要：
Disclosed is use of a thieno[3,2-d]pyrimidin-4-one compound represented by general formula (I). Definition of each substituent is as stated in the description and claims, and the compound is used for preparing medicines for treating and/or preventing liver fibrosis and related diseases or preparing a DPP-4 inhibitor, or is used as a DPP-4 inhibitor.
公开/授权文献
信息查询
IPC分类:
